Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
| Autor: | van Ramshorst, Mette S1, van der Voort, Anna1, van Werkhoven, Erik D2, Mandjes, Ingrid A2, Kemper, Inge1, Dezentjé, Vincent O1,3, Oving, Irma M4, Honkoop, Aafke H5, Tick, Lidwine W6, van de Wouw, Agnes J7, Mandigers, Caroline M8, van Warmerdam, Laurence J9, Wesseling, Jelle10, Vrancken Peeters, Marie-Jeanne T11, Linn, Sabine C1,12, Sonke, Gabe S1 g.sonke@nki.nl, Dutch Breast Cancer Research Group (BOOG) (CORPORATE AUTHOR) |
|---|---|
| Zdroj: | Lancet Oncology. Dec2018, Vol. 19 Issue 12, p1630-1640. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|